本页面由Tiger Trade Technology Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

7.36
-0.4600-5.88%
盘后:7.390.0300+0.41%19:30 EDT
成交量:101.87万
成交额:759.27万
市值:6.41亿
市盈率:-3.46
高:7.77
开:7.77
低:7.33
收:7.82
52周最高:36.26
52周最低:6.65
股本:8,715.70万
流通股本:7,188.81万
量比:1.01
换手率:1.42%
股息:- -
股息率:- -
每股收益(TTM):-2.1289
每股收益(LYR):-1.8700
净资产收益率:-52.74%
总资产收益率:-31.82%
市净率:1.49
市盈率(LYR):-3.94

数据加载中...

2024/12/10

重要事件披露

Form 8-K - Current report
2024/12/04

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/09/27

重要事件披露

Form 8-K - Current report
2024/08/06

重要事件披露

Form 8-K - Current report
2024/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/02

重要事件披露

Form 8-K - Current report
2024/06/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

重要事件披露

Form 8-K - Current report
2024/06/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]